Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case?
about
A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumabSinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapyDetection of a fluorescent-labeled avidin-nucleic acid nanoassembly by confocal laser endomicroscopy in the microvasculature of chronically inflamed intestinal mucosa.Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitisSerious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: A literature review.Serious infections associated with anticytokine therapies in the rheumatic diseases.Fungal infections in bone marrow transplant recipients.A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety.Review of fungal outbreaks and infection prevention in healthcare settings during construction and renovation.Differential transcriptional profiles induced by amphotericin B formulations on human monocytes during response to hyphae of Aspergillus fumigatus.Suppressed wound healing in a patient with rheumatoid arthritis taking leflunomide (arava).Involvement of toll-like receptor 2 in experimental invasive pulmonary aspergillosis.Filamentous fungi in a tertiary care hospital: environmental surveillance and susceptibility to antifungal drugs.Emergence of Legionella pneumophila Pneumonia in Patients Receiving Tumor Necrosis Factor- Antagonists
P2860
Q28282330-07A12FE1-3EB2-4C3C-943D-9C5EF0553A2FQ34413227-921FC009-6F6F-489D-9515-95CCA45235FDQ34960433-7307F8AA-BC0E-4809-AD36-69C1743D13D3Q35019838-564A910C-01B6-4079-B5FD-23019B10665FQ35705082-B1BC5A78-F9BC-45A3-BA09-0571DA90B610Q35937819-55A3A487-DC0A-4BC9-95D6-347F7E72BF1CQ36382582-DF080056-28AB-40EE-B806-DF071EBD4FD8Q37814549-C675CA95-7301-464A-B8FF-475D2A806827Q37918330-8AC4ACF9-2CF6-4BEA-9723-9814D4A69A2EQ38419604-5724BFDB-E0BE-4CD0-9EDF-79771F83D30BQ39661366-1BD73A88-FBA8-4E2B-8005-506D9900A9DEQ40704946-238A2746-D8A4-45F6-9350-648589528790Q43013642-51D657D6-154C-4A5E-A170-48F28438BCE8Q46362922-110D6E4B-87AC-49A4-81D3-D582E44C1DF4Q57779961-8776BB0B-FE1D-4719-BF77-2EEF2D471659
P2860
Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case?
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Invasive pulmonary aspergillos ...... le healthcare-associated case?
@ast
Invasive pulmonary aspergillos ...... le healthcare-associated case?
@en
type
label
Invasive pulmonary aspergillos ...... le healthcare-associated case?
@ast
Invasive pulmonary aspergillos ...... le healthcare-associated case?
@en
prefLabel
Invasive pulmonary aspergillos ...... le healthcare-associated case?
@ast
Invasive pulmonary aspergillos ...... le healthcare-associated case?
@en
P2093
P2860
P356
P1476
Invasive pulmonary aspergillos ...... le healthcare-associated case?
@en
P2093
Anthony C Campagna
David Shaz
Donald E Craven
Francesco G De Rosa
Paul E Dellaripa
Urmila Khettry
P2860
P304
P356
10.1086/502250
P577
2003-07-01T00:00:00Z